首页> 外文期刊>Nature >Tat-specif ic cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
【24h】

Tat-specif ic cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia

机译:Tat特异性细胞毒性T淋巴细胞在原发性病毒血症消退过程中选择SIV逃逸变体

获取原文
获取原文并翻译 | 示例
           

摘要

Human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections are characterized by early peaks of viraemia that decline as strong cellular immune responses develop. Although it has been shown that virus-specific CD8-positive cytotoxic T lymphocytes (CTLs) exert selective pressure during HIV and SIV infection, the data have been controversial. Here we show that Tat-specific CD8-positive T-lymphocyte responses select for new viral escape variants during the acute phase of infection. We sequenced the entire virus immediately after the acute phase, and found that amino-acid replacements accumulated primarily in Tat CTL epitopes. This implies that Tat-specific CTLs may be significantly involved in controlling wild-type virus replication, and suggests that responses against viral proteins that are expressed early during the viral life cycle might be attractive targets for HIV vaccine development.
机译:人免疫缺陷病毒(HIV)和猿猴免疫缺陷病毒(SIV)感染的特征是病毒血症的早期高峰,随着强烈的细胞免疫反应的发展,病毒血症的高峰期逐渐减少。尽管已经显示病毒特异性CD8阳性细胞毒性T淋巴细胞(CTL)在HIV和SIV感染过程中施加选择性压力,但该数据一直存在争议。在这里,我们显示Tat特异性CD8阳性T淋巴细胞反应在感染的急性期选择了新的病毒逃逸变异体。我们在急性期后立即对整个病毒进行了测序,发现氨基酸置换主要在Tat CTL表位中积累。这意味着Tat特异的CTL可能与控制野生型病毒的复制有很大关系,并且表明针对在病毒生命周期早期表达的病毒蛋白的应答可能是HIV疫苗开发的有吸引力的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号